| Market Capitalization (Millions $) |
5,059 |
| Shares
Outstanding (Millions) |
311 |
| Employees |
103 |
| Revenues (TTM) (Millions $) |
- |
| Net Income (TTM) (Millions $) |
-287 |
| Cash Flow (TTM) (Millions $) |
-19 |
| Capital Exp. (TTM) (Millions $) |
0 |
Business Description
Erasca Inc is a biotech company dedicated to discovering and developing innovative therapies for the treatment of cancer. The company was founded in 2018 and is headquartered in San Diego, California. Its mission is to eradicate cancer by developing precision medicines that target the root causes of the disease.
The core technology of Erasca is focused on precision medicine, which involves developing targeted therapies based on genetic and molecular information of individual patients. This technology allows the company to develop drugs that specifically target cancer cells, while minimizing harm to healthy cells in the body. Erasca has a number of proprietary drug discovery platforms that enable the development of these targeted therapies.
One of Erasca's flagship products is Erava, a targeted therapy designed to treat patients with solid tumors. This drug is currently in phase 1/2 clinical trials and has shown promising results in early testing. Erasca is also developing other products, including ERAS-007, a potential treatment for patients with KRAS-mutated cancer, and a range of antibody-drug conjugates (ADCs) that target different types of cancer cells.
The company's leadership team is composed of industry veterans with extensive experience in the development of oncology drugs. They bring a diverse range of expertise across drug discovery, clinical development, and regulatory affairs. Erasca has also formed strategic collaborations with leading institutions in the field of cancer research, such as MD Anderson Cancer Center and Children's Hospital Los Angeles.
Erasca has received significant support from institutional investors, raising more than $300 million in funding since its inception. The company is also committed to social responsibility, partnering with organizations like Stand Up To Cancer to help fund cancer research and raise awareness about the disease. Overall, Erasca represents a promising new entrant in the field of oncology drug development, with a strong focus on precision medicine and a commitment to making a meaningful impact in the fight against cancer.
Company Address: 3115 Merryfield Row San Diego 92121 CA
Company Phone Number: 465-6511 Stock Exchange / Ticker: NASDAQ ERAS
|
1.88% 